Much-Improved Outcomes for Follicular Lymphoma Transformed to DLBCL in the Rituximab Era, Study Finds

Although histological transformation to diffuse large B-cell lymphoma (DLBCL) remains a common complication of follicular lymphoma, patient survival has increased significantly since the introduction of rituximab about 2 decades ago.

Related Keywords

,Genentech ,Image Credit ,Cancer Medicine ,End Results ,Dlbcl ,Follicular Lymphoma ,Rituximab ,